Remove 2012 Remove Molecular Biology Remove Therapies
article thumbnail

Advancing CAR-T therapy: how CD5 modulation is shaping cancer treatment

Drug Target Review

What potential advantages does the CD5 modulation strategy offer over traditional CAR-T therapies? MR : Chimeric antigen receptor T-cell (CAR-T) therapy is very effective in treating patients with B-cell lymphoma, leukemia, and multiple myeloma, where we have six FDA-approved drugs.

article thumbnail

Europe: Where is the drug discovery innovation?

Drug Discovery World

A more established Amsterdam-based enterprise is gene therapy company uniQure, developer of etranacogene dezaparvovec, the first gene therapy for haemophilia B, which was approved for use in the US in November 2022 and in the EU in February 2023. The rights for etranacogene dezaparvovec were subsequently sold to CSL Pharmaceuticals.

Drugs 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The role of STRIs in cancer

Drug Target Review

By directly interfering with the eIF4F complex, eFFECTOR’s STRIs provide a promising avenue for disrupting the core mechanisms of cancer, offering the potential to improve patient outcomes and overcome the limitations of traditional cancer therapies. Dr Worland has served on the board of directors of Tracon Pharmaceuticals, Inc.,

article thumbnail

Leveraging ADCs in precision oncology strategy

Drug Target Review

What role do ADCs play in Caris’ strategy for targeted cancer therapy, particularly in terms of patient-specific treatment plans? At a base-layer, Caris’ comprehensive molecular profiling that we perform for patients today can identify predictive biomarkers for current FDA-approved ADCs.

article thumbnail

Welcome to Asimov Press

Codon

Molecular biology, as the field came to be called 3 , pushed biology from an object of study, driven forward by gentleman scientists and precocious country clergymen, into a tool with which to solve urgent problems. CRISPR gene-editing was invented in 2012 and applied to human embryos soon after.

article thumbnail

Battling antibiotic resistance in the lab and the clinic

Broad Institute

He majored in biological chemistry at the University of Chicago and during his junior year, he had a fortuitous meeting with his academic advisor about finding a student research position that would let him dive more deeply into the molecular details of biological systems. A combined MD/PhD program offered both opportunities.

Hospitals 137
article thumbnail

Codon: Notes on Progress #2

Codon

Related news : “More than 200 people have been treated with experimental CRISPR therapies.” The landmark paper enabled revolutions in insulin biomanufacturing, CAR-T therapies, and the bioproduction of most modern vaccines; in other words, much of what we take for granted today. Lots of gene therapy data this week.

DNA 52